These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30381987)

  • 1. International consensus on quality standards for brain health-focused care in multiple sclerosis.
    Hobart J; Bowen A; Pepper G; Crofts H; Eberhard L; Berger T; Boyko A; Boz C; Butzkueven H; Celius EG; Drulovic J; Flores J; Horáková D; Lebrun-Frénay C; Marrie RA; Overell J; Piehl F; Rasmussen PV; Sá MJ; Sîrbu CA; Skromne E; Torkildsen Ø; van Pesch V; Vollmer T; Zakaria M; Ziemssen T; Giovannoni G
    Mult Scler; 2019 Nov; 25(13):1809-1818. PubMed ID: 30381987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis.
    Medina-Polo J; Adot JM; Allué M; Arlandis S; Blasco P; Casanova B; Matías-Guiu J; Madurga B; Meza-Murillo ER; Müller-Arteaga C; Rodríguez-Acevedo B; Vara J; Zubiaur MC; López-Fando L
    Neurourol Urodyn; 2020 Feb; 39(2):762-770. PubMed ID: 31943361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus recommendations on the management of multiple sclerosis patients in Argentina.
    Cristiano E; Rojas JI; Alonso R; Alvez Pinheiro A; Bacile EA; Balbuena ME; Barboza AG; Bestoso S; Burgos M; Cáceres F; Carnero Contentti E; Curbelo MC; Deri N; Fernandez Liguori N; Gaitán MI; Garcea O; Giunta D; Halfon MJ; Hryb JP; Jacobo M; Kohler E; Luetic GG; Maglio I; Martínez AD; Míguez J; Nofal PG; Patrucco L; Piedrabuena R; Rotta Escalante R; Saladino ML; Silva BA; Sinay V; Tkachuk V; Villa A; Vrech C; Ysrraelit MC; Correale J
    J Neurol Sci; 2020 Feb; 409():116609. PubMed ID: 31816524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadian Expert Panel Recommendations for MRI Use in MS Diagnosis and Monitoring.
    Traboulsee A; Létourneau-Guillon L; Freedman MS; O'Connor PW; Bharatha A; Chakraborty S; Girard JM; Giuliani F; Lysack JT; Marriott JJ; Metz LM; Morrow SA; Oh J; Sharma M; Vandorpe RA; Vertinsky TA; Wadhwa VS; von Riedemann S; Li DK
    Can J Neurol Sci; 2015 May; 42(3):159-67. PubMed ID: 25896163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches to the management of agents used for the treatment of multiple sclerosis: consensus statements from a panel of U.S. managed care pharmacists and physicians.
    Miller RM; Happe LE; Meyer KL; Spear RJ
    J Manag Care Pharm; 2012; 18(1):54-62. PubMed ID: 22235955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
    Rae-Grant A; Day GS; Marrie RA; Rabinstein A; Cree BAC; Gronseth GS; Haboubi M; Halper J; Hosey JP; Jones DE; Lisak R; Pelletier D; Potrebic S; Sitcov C; Sommers R; Stachowiak J; Getchius TSD; Merillat SA; Pringsheim T
    Neurology; 2018 Apr; 90(17):777-788. PubMed ID: 29686116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timely intervention, monitoring and education MATTERS in MS (TIME MATTERS in MS): Development of a globally applicable quality improvement tool.
    Hobart J; Butzkueven H; Haartsen J; Ziemssen T; Lane T; Giovannoni G
    Mult Scler J Exp Transl Clin; 2022; 8(3):20552173221124023. PubMed ID: 36105273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology.
    Brieva L; Estruch BC; Merino JAG; Meca-Lallana V; Río J; Rodríguez-Antigüedad A; Agüera E; Ara JR; Luque AA; Garcia CA; Blanco Y; Castillo-Triviño T; Costa-Frossard L; González Platas M; Pascual LL; Llaneza-González M; Ginés MLM; Matías-Guiu J; Meca-Lallana JE; Bilbao MM; Sempere AP; Romero-Pinel L; Saiz A; Moral E
    Mult Scler Relat Disord; 2022 Jul; 63():103805. PubMed ID: 35512501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Argentinean consensus recommendations for the use of telemedicine in clinical practice in adult people with multiple sclerosis.
    Alonso R; Eizaguirre MB; López P; Silva B; Rojas JI; Sinay V; Tkachuk V; Patrucco L; Carra A; Bruno D; Pagani Cassara F; Fernández Liguori N; Tavolini D; Camerlingo S; Garcea O; Galiani A; Mainella C; Barboza A; Luetic G; Carnero Contentti E
    Neurol Sci; 2023 Feb; 44(2):667-676. PubMed ID: 36319902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus recommendations for the diagnosis and treatment of multiple sclerosis in Kuwait.
    Alroughani R; Ashkanani A; Al-Hashel J; Khan R; Thussu A; Alexander KJ; Vembu P; Sharfuddin K; Lamdhade S; John JK; Alkhashan S; Abualmelh M; Al-Shammri S
    Clin Neurol Neurosurg; 2016 Apr; 143():51-64. PubMed ID: 26896783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A consensus review on the development of palliative care for patients with chronic and progressive neurological disease.
    Oliver DJ; Borasio GD; Caraceni A; de Visser M; Grisold W; Lorenzl S; Veronese S; Voltz R
    Eur J Neurol; 2016 Jan; 23(1):30-8. PubMed ID: 26423203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain health: time matters in multiple sclerosis.
    Giovannoni G; Butzkueven H; Dhib-Jalbut S; Hobart J; Kobelt G; Pepper G; Sormani MP; Thalheim C; Traboulsee A; Vollmer T
    Mult Scler Relat Disord; 2016 Sep; 9 Suppl 1():S5-S48. PubMed ID: 27640924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward a Shared-Care Model of Relapsing-Remitting Multiple Sclerosis: Role of the Primary Care Practitioner.
    Oh J; Gagné-Brosseau MS; Guenette M; Larochelle C; Lemieux F; Menon S; Morrow SA; Poliquin-Lasnier L; Roy-Hewitson C; Rush C; Trudelle AM; Giacomini PS
    Can J Neurol Sci; 2018 May; 45(3):304-312. PubMed ID: 29756588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.
    Montalban X; Gold R; Thompson AJ; Otero-Romero S; Amato MP; Chandraratna D; Clanet M; Comi G; Derfuss T; Fazekas F; Hartung HP; Havrdova E; Hemmer B; Kappos L; Liblau R; Lubetzki C; Marcus E; Miller DH; Olsson T; Pilling S; Selmaj K; Siva A; Sorensen PS; Sormani MP; Thalheim C; Wiendl H; Zipp F
    Eur J Neurol; 2018 Feb; 25(2):215-237. PubMed ID: 29352526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing gold standards for System-Level Measures: a modified Delphi consensus process.
    Doolan-Noble F; Barson S; Lyndon M; Cullinane F; Gray J; Stokes T; Gauld R
    Int J Qual Health Care; 2019 Apr; 31(3):205-211. PubMed ID: 29889227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis care units in Latin America: Consensus recommendations about its objectives and functioning implementation.
    Cristiano E; Abad P; Becker J; Carrá A; Correale J; Flores J; Fruns M; Garcea O; Garcia Bónitto J; Gracia F; Hamuy F; Navas C; Patrucco L; Rivera V; Velazquez M; Rojas JI
    J Neurol Sci; 2021 Oct; 429():118072. PubMed ID: 34509134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of diagnostic and treatment practices for multiple sclerosis in Europe.
    Fernández O; Delvecchio M; Edan G; Fredrikson S; Gionvannoni G; Hartung HP; Havrdova E; Kappos L; Pozzilli C; Soerensen PS; Tackenberg B; Vermersch P; Comi G
    Eur J Neurol; 2017 Mar; 24(3):516-522. PubMed ID: 28139062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 360-degree Delphi: addressing sociotechnical challenges of healthcare IT.
    Waldmüller H; Spreckelsen C; Rudat H; Krumm N; Rolke R; Jonas SM
    BMC Med Inform Decis Mak; 2020 Jun; 20(1):101. PubMed ID: 32503609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-line urological evaluation in multiple sclerosis: validation of a specific decision-making algorithm.
    Amarenco G; Chartier-Kastler E; Denys P; Jean JL; de Sèze M; Lubetzski C
    Mult Scler; 2013 Dec; 19(14):1931-7. PubMed ID: 23698129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.